引用本文:韦金涛,李泽桦(综述),区彩文(审校).鼠李糖乳杆菌GG在心血管疾病中的研究进展[J].中国临床新医学,2022,15(4):368-375.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 197次   下载 368 本文二维码信息
码上扫一扫!
分享到: 微信 更多
鼠李糖乳杆菌GG在心血管疾病中的研究进展
韦金涛,李泽桦(综述),区彩文(审校)
510000 广州,南方医科大学附属珠江医院
摘要:
[摘要] 心血管疾病负担持续加重是目前全球面临的重大健康问题。靶向肠道菌群是降低心血管疾病发病率和病死率的潜在有效策略。近年来,益生菌疗法的兴起为心血管疾病的预防和治疗提供了新思路。鼠李糖乳杆菌GG(LGG)通过抗炎、抗氧化应激、调节肠道菌群和保护肠屏障等多种机制在心血管疾病的预防和治疗中展现出巨大的潜力。该文对近年来LGG在心血管疾病中的研究进展作一综述。
关键词:  鼠李糖乳杆菌GG  心血管疾病  预防  治疗
DOI:10.3969/j.issn.1674-3806.2022.04.20
分类号:R 54
基金项目:国家自然科学基金资助项目(编号:81871504)
Research progress of Lactobacillus rhamnosus Gorbach-Goldin in cardiovascular diseases
WEI Jin-tao, LI Ze-hua, OU Cai-wen
Zhujiang Hospital Affiliated to Southern Medical University, Guangzhou 510000, China
Abstract:
[Abstract] The increasing burden of cardiovascular diseases is a major health problem facing the world at present. Targeting gut microbiota is a potentially effective strategy to reduce the incidence and mortality of cardiovascular diseases. In recent years, the rise of probiotic therapy has provided new ideas for the prevention and treatment of cardiovascular diseases. Lactobacillus rhamnosus Gorbach-Goldin(LGG) shows great potential in the prevention and treatment of cardiovascular diseases through various mechanisms, such as anti-inflammation, anti-oxidative stress, regulation of gut microbiota, and protection of intestinal barrier.This paper reviews the research progress of LGG in cardiovascular diseases in recent years.
Key words:  Lactobacillus rhamnosus Gorbach-Goldin(LGG)  Cardiovascular diseases(CVD)  Prevention  Treatment